Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Moelis is advising Entain’s board and the group’s recently formed capital allocation committee, and any disposals will be of brands that are not integrated into the company’s technology platform, which makes...
...The company’s value had increased since then and it could now be worth roughly €4bn in a deal, one of the people said.Deliberations were at an early stage and the company could also pursue the sale of a...
...The Biosecure Act would prohibit US companies receiving federal grant money from working with four Chinese biotech companies, including WuXi AppTec and its sister company WuXi Biologics, which produce active...
...A small number of people in equities are trialling a rival offering from US data and software company FactSet, which costs about a third of the price, one of the people said....
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...index rises, and player numbers and average spend changes”....
...The Santa Clara-based company’s intravascular lithotripsy treatment involves a catheter producing electrical impulses being inserted into patients’ arteries, helping to break up the build-up of calcium....
...“The big issue we have is that our member companies, in order to bring active ingredients and finished drug products from China to the EU, need certification from certain authorities,” Bicane said....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Eli Lilly said that it plans to submit the results to the US Food and Drug Administration and other medicine regulators worldwide to seek approval for tirzepatide as a sleep apnoea treatment beginning this...
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...Greencore is the latest consumer company in the UK to be targeted by Oasis after several successful activist campaigns....
...Artfarm — a hospitality company founded by Iwan and Manuela Wirth, the couple behind the Hauser & Wirth gallery — bought the Groucho in 2022 for £40mn, promising to reinvigorate it and possibly expand overseas...
...But unless the Seattle-based company acquires more healthcare groups, “its overall share of the prescription dispensing market will likely remain in the low single digits for the foreseeable future”, he...
...Promises from governments and pharmaceutical companies to boost vaccine equity and pandemic preparedness in anticipation of the next global health crisis have fallen down the political agenda, while disputes...
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...in 1995, of being “a company with a broken business model and terrible accounting”....
...Choice said its exchange offer for Wyndham, which valued the company at $7bn on current prices and $9bn including debt, had expired and it was withdrawing its nomination of an independent director to Wyndham...
...company’s share buyback programme....
...But according to Holst, who has worked as a consultant for the company, it has struggled to develop small-molecule GLP-1 drugs, which are much easier and cheaper for manufacturers to produce at scale....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against US pharmacy chains such as CVS and Walgreens. Read more here...
International Edition